A61K 31/43
Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring
Official title: Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula [IMAGE cpc-sch-A61K-0952.gif], e.g. penicillins, penems
A61K31/43 (Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring) appears on 990 US grants and 1,404 published applications in this corpus.
Search patents in A61K- Granted patents
- 990
- Published applications
- 1,404
- Assignees
- 733
- Inventors
- 2,755
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 18 | 0 |
| 1977 | 7 | 0 |
| 1978 | 12 | 0 |
| 1979 | 5 | 0 |
| 1980 | 8 | 0 |
| 1981 | 14 | 0 |
| 1982 | 7 | 0 |
| 1983 | 12 | 0 |
| 1984 | 18 | 0 |
| 1985 | 26 | 0 |
| 1986 | 5 | 0 |
| 1987 | 8 | 0 |
| 1988 | 5 | 0 |
| 1989 | 6 | 0 |
| 1990 | 8 | 0 |
| 1991 | 7 | 0 |
| 1992 | 4 | 0 |
| 1993 | 6 | 0 |
| 1994 | 1 | 0 |
| 1995 | 7 | 0 |
| 1996 | 2 | 0 |
| 1997 | 17 | 0 |
| 1998 | 11 | 0 |
| 1999 | 14 | 0 |
| 2000 | 16 | 0 |
| 2001 | 16 | 8 |
| 2002 | 22 | 33 |
| 2003 | 23 | 34 |
| 2004 | 14 | 53 |
| 2005 | 9 | 30 |
| 2006 | 12 | 45 |
| 2007 | 18 | 41 |
| 2008 | 5 | 33 |
| 2009 | 10 | 40 |
| 2010 | 23 | 36 |
| 2011 | 17 | 49 |
| 2012 | 27 | 35 |
| 2013 | 24 | 41 |
| 2014 | 30 | 92 |
| 2015 | 29 | 73 |
| 2016 | 53 | 97 |
| 2017 | 57 | 72 |
| 2018 | 49 | 77 |
| 2019 | 44 | 77 |
| 2020 | 49 | 77 |
| 2021 | 51 | 91 |
| 2022 | 34 | 66 |
| 2023 | 42 | 62 |
| 2024 | 36 | 60 |
| 2025 | 33 | 46 |
| 2026 | 19 | 36 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Medication that protects the intestinal microbiota and their preparation methods and applications6 Oct 2026US 12,751,921 B2University of Science and Technology of China
- Short conjugated oligoelectrolytesand antibiotics22 Sep 2026US 12,740,950 B2Nanyang Technological University
- Compounds for the treatment of bacterial infections and potentiation of antibiotics8 Sep 2026US 12,728,105 B2Georgia State University Research Foundation, Inc.
- Use of membrane inhibitors to enhance vaccine development against enveloped viruses8 Sep 2026US 12,728,161 B2Cornell University
- Pharmaceutical composition comprising sulbactam and avibactam, and application thereof4 Aug 2026US 12,697,325 B2Tennor Therapeutics (Suzhou) Limited
- Combination therapy for bacterial infections comprising zinc-chelator, beta-lactam antibiotic and serine beta-lactamase inhibitor8 Oct 2026US 2026/0306526 A1Adjutec Pharma AS
- Tp0751 chimera-containing vaccine1 Oct 2026US 2026/0297141 A1University of Washington
- Compounds for restoring susceptibility to beta-lactam antibiotics24 Sep 2026US 2026/0284011 A1University of Notre Dame du Lac
- Chimeric endolysins with activity against streptococci and staphylococci17 Sep 2026US 2026/0275317 A1
- Transdermal drug delivery patch system for controlled and sustained delivery of tizanidine base10 Sep 2026US 2026/0263383 A1
Most cited
By later US patents
- Pharmaceutical and cosmetic carrier or composition for topical application284US 6,911,211 B2Foamix Ltd. · 2005
- Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth243US 6,861,053 B1Cedars-Sinai Medical Center · 2005
- Probiotic recolonisation therapy240US 8,460,648 B22013
- Method for treatment of idiopathic inflammatory bowel disease (IIBD)229US 5,599,795 A1997
- Pharmaceutical formulations for parenteral use208US 5,024,998 AUniversity of Florida · 1991